+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peripheral Neuropathy Treatment Market 2025-2029- Product Image
Peripheral Neuropathy Treatment Market 2025-2029- Product Image
New

Peripheral Neuropathy Treatment Market 2025-2029

  • PDF Icon

    Report

  • 233 Pages
  • April 2025
  • Region: Global
  • TechNavio
  • ID: 5188677
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The peripheral neuropathy treatment market is forecasted to grow by USD 481.6 million during 2024-2029, accelerating at a CAGR of 4.5% during the forecast period. The report on the peripheral neuropathy treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of peripheral neuropathy, recent drug approvals for peripheral neuropathy, and rising awareness of peripheral neuropathy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The peripheral neuropathy treatment market is segmented as below:

By Type

  • Diabetic
  • Chemotherapy
  • Others

By Therapy

  • Pharmacological therapies
  • Non pharmacological therapies

By Diagnostic Methods

  • Blood test
  • Biopsy
  • Imaging

By End-user

  • Hospitals and clinics
  • Retail pharmacy
  • Online pharmacy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the strong drug pipeline as one of the prime reasons driving the peripheral neuropathy treatment market growth during the next few years. Also, technological advances with new formulations of drugs and increase in research and development associated with peripheral neuropathy treatment will lead to sizable demand in the market.

The report on the peripheral neuropathy treatment market covers the following areas:

  • Peripheral Neuropathy Treatment Market sizing
  • Peripheral Neuropathy Treatment Market forecast
  • Peripheral Neuropathy Treatment Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peripheral neuropathy treatment market vendors that include Apotex Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Cadila Pharmaceuticals Ltd., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Grunenthal GmbH, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc. Also, the peripheral neuropathy treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Peripheral Neuropathy Treatment Market 2019 - 2023
Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2019 - 2023 ($ million)
5.2 Type segment analysis 2019 - 2023
Historic Market Size - Type Segment 2019 - 2023 ($ million)
5.3 Therapy segment analysis 2019 - 2023
Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
5.4 Diagnostic Methods segment analysis 2019 - 2023
Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
5.5 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.6 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.7 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 The AI impact on Global Peripheral Neuropathy Treatment Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type
8.1 Market segments
Chart on Type - Market share 2024-2029 (%)
Data Table on Type - Market share 2024-2029 (%)
8.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
8.3 Diabetic - Market size and forecast 2024-2029
Chart on Diabetic - Market size and forecast 2024-2029 ($ million)
Data Table on Diabetic - Market size and forecast 2024-2029 ($ million)
Chart on Diabetic - Year-over-year growth 2024-2029 (%)
Data Table on Diabetic - Year-over-year growth 2024-2029 (%)
8.4 Chemotherapy - Market size and forecast 2024-2029
Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
9 Market Segmentation by Therapy
9.1 Market segments
Chart on Therapy - Market share 2024-2029 (%)
Data Table on Therapy - Market share 2024-2029 (%)
9.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
9.3 Pharmacological therapies - Market size and forecast 2024-2029
Chart on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Data Table on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Chart on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
9.4 Non pharmacological therapies - Market size and forecast 2024-2029
Chart on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Data Table on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Chart on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
Data Table on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
9.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
10 Market Segmentation by Diagnostic Methods
10.1 Market segments
Chart on Diagnostic Methods - Market share 2024-2029 (%)
Data Table on Diagnostic Methods - Market share 2024-2029 (%)
10.2 Comparison by Diagnostic Methods
Chart on Comparison by Diagnostic Methods
Data Table on Comparison by Diagnostic Methods
10.3 Blood test - Market size and forecast 2024-2029
Chart on Blood test - Market size and forecast 2024-2029 ($ million)
Data Table on Blood test - Market size and forecast 2024-2029 ($ million)
Chart on Blood test - Year-over-year growth 2024-2029 (%)
Data Table on Blood test - Year-over-year growth 2024-2029 (%)
10.4 Biopsy - Market size and forecast 2024-2029
Chart on Biopsy - Market size and forecast 2024-2029 ($ million)
Data Table on Biopsy - Market size and forecast 2024-2029 ($ million)
Chart on Biopsy - Year-over-year growth 2024-2029 (%)
Data Table on Biopsy - Year-over-year growth 2024-2029 (%)
10.5 Imaging - Market size and forecast 2024-2029
Chart on Imaging - Market size and forecast 2024-2029 ($ million)
Data Table on Imaging - Market size and forecast 2024-2029 ($ million)
Chart on Imaging - Year-over-year growth 2024-2029 (%)
Data Table on Imaging - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Diagnostic Methods
Market opportunity by Diagnostic Methods ($ million)
Data Table on Market opportunity by Diagnostic Methods ($ million)
11 Market Segmentation by End-user
11.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
11.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
11.3 Hospitals and clinics - Market size and forecast 2024-2029
Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
11.4 Retail pharmacy - Market size and forecast 2024-2029
Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
11.5 Online pharmacy - Market size and forecast 2024-2029
Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
11.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
12.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
13.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
13.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
13.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
13.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
13.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
13.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
13.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
13.8 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
13.9 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
13.10 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
13.11 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
13.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
13.13 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
13.14 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
13.15 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
13.16 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
13.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
14.1 Market drivers
14.2 Market challenges
14.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
14.4 Market opportunities/restraints
15 Competitive Landscape
15.1 Overview
15.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
15.3 Landscape disruption
Overview on factors of disruption
15.4 Industry risks
Impact of key risks on business
16 Competitive Analysis
16.1 Companies profiled
Companies covered
16.2 Company ranking index
Company ranking index
16.3 Market positioning of companies
Matrix on companies position and classification
16.4 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
SWOT
16.5 ASSERTIO HOLDINGS INC.
ASSERTIO HOLDINGS INC. - Overview
ASSERTIO HOLDINGS INC. - Product / Service
ASSERTIO HOLDINGS INC. - Key offerings
SWOT
16.6 AstraZeneca Plc
AstraZeneca Plc - Overview
AstraZeneca Plc - Product / Service
AstraZeneca Plc - Key news
AstraZeneca Plc - Key offerings
SWOT
16.7 Cadila Pharmaceuticals Ltd.
Cadila Pharmaceuticals Ltd. - Overview
Cadila Pharmaceuticals Ltd. - Product / Service
Cadila Pharmaceuticals Ltd. - Key offerings
SWOT
16.8 Cipla Inc.
Cipla Inc. - Overview
Cipla Inc. - Business segments
Cipla Inc. - Key news
Cipla Inc. - Key offerings
Cipla Inc. - Segment focus
SWOT
16.9 Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co. Ltd. - Overview
Daiichi Sankyo Co. Ltd. - Product / Service
Daiichi Sankyo Co. Ltd. - Key offerings
SWOT
16.10 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
16.11 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT
16.12 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
SWOT
16.13 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
SWOT
16.14 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
16.15 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
16.16 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
SWOT
16.17 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
16.18 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
SWOT
17 Appendix
17.1 Scope of the report
17.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
17.3 Currency conversion rates for US$
Currency conversion rates for US$
17.4 Research methodology
Research methodology
17.5 Data procurement
Information sources
17.6 Data validation
Data validation
17.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
17.8 Data synthesis
Data synthesis
17.9 360 degree market analysis
360 degree market analysis
17.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits 7: Executive Summary - Chart on Market Segmentation by Diagnostic Methods
Exhibits 8: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 9: Executive Summary - Chart on Incremental Growth
Exhibits 10: Executive Summary - Data Table on Incremental Growth
Exhibits 11: Executive Summary - Chart on Company Market Positioning
Exhibits 12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 13: Overview on criticality of inputs and factors of differentiation
Exhibits 14: Overview on factors of disruption
Exhibits 15: Impact of drivers and challenges in 2024 and 2029
Exhibits 16: Parent Market
Exhibits 17: Data Table on - Parent Market
Exhibits 18: Market characteristics analysis
Exhibits 19: Value chain analysis
Exhibits 20: Offerings of companies included in the market definition
Exhibits 21: Market segments
Exhibits 22: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 26: Historic Market Size - Data Table on Global Peripheral Neuropathy Treatment Market 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Type Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Diagnostic Methods Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits 31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 33: Five forces analysis - Comparison between 2024 and 2029
Exhibits 34: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 37: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 38: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 39: Chart on Market condition - Five forces 2024 and 2029
Exhibits 40: Chart on Type - Market share 2024-2029 (%)
Exhibits 41: Data Table on Type - Market share 2024-2029 (%)
Exhibits 42: Chart on Comparison by Type
Exhibits 43: Data Table on Comparison by Type
Exhibits 44: Chart on Diabetic - Market size and forecast 2024-2029 ($ million)
Exhibits 45: Data Table on Diabetic - Market size and forecast 2024-2029 ($ million)
Exhibits 46: Chart on Diabetic - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Diabetic - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Chemotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 49: Data Table on Chemotherapy - Market size and forecast 2024-2029 ($ million)
Exhibits 50: Chart on Chemotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Chemotherapy - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 53: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 54: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 56: Market opportunity by Type ($ million)
Exhibits 57: Data Table on Market opportunity by Type ($ million)
Exhibits 58: Chart on Therapy - Market share 2024-2029 (%)
Exhibits 59: Data Table on Therapy - Market share 2024-2029 (%)
Exhibits 60: Chart on Comparison by Therapy
Exhibits 61: Data Table on Comparison by Therapy
Exhibits 62: Chart on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Exhibits 63: Data Table on Pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Exhibits 64: Chart on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Pharmacological therapies - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Exhibits 67: Data Table on Non pharmacological therapies - Market size and forecast 2024-2029 ($ million)
Exhibits 68: Chart on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Non pharmacological therapies - Year-over-year growth 2024-2029 (%)
Exhibits 70: Market opportunity by Therapy ($ million)
Exhibits 71: Data Table on Market opportunity by Therapy ($ million)
Exhibits 72: Chart on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits 73: Data Table on Diagnostic Methods - Market share 2024-2029 (%)
Exhibits 74: Chart on Comparison by Diagnostic Methods
Exhibits 75: Data Table on Comparison by Diagnostic Methods
Exhibits 76: Chart on Blood test - Market size and forecast 2024-2029 ($ million)
Exhibits 77: Data Table on Blood test - Market size and forecast 2024-2029 ($ million)
Exhibits 78: Chart on Blood test - Year-over-year growth 2024-2029 (%)
Exhibits 79: Data Table on Blood test - Year-over-year growth 2024-2029 (%)
Exhibits 80: Chart on Biopsy - Market size and forecast 2024-2029 ($ million)
Exhibits 81: Data Table on Biopsy - Market size and forecast 2024-2029 ($ million)
Exhibits 82: Chart on Biopsy - Year-over-year growth 2024-2029 (%)
Exhibits 83: Data Table on Biopsy - Year-over-year growth 2024-2029 (%)
Exhibits 84: Chart on Imaging - Market size and forecast 2024-2029 ($ million)
Exhibits 85: Data Table on Imaging - Market size and forecast 2024-2029 ($ million)
Exhibits 86: Chart on Imaging - Year-over-year growth 2024-2029 (%)
Exhibits 87: Data Table on Imaging - Year-over-year growth 2024-2029 (%)
Exhibits 88: Market opportunity by Diagnostic Methods ($ million)
Exhibits 89: Data Table on Market opportunity by Diagnostic Methods ($ million)
Exhibits 90: Chart on End-user - Market share 2024-2029 (%)
Exhibits 91: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 92: Chart on Comparison by End-user
Exhibits 93: Data Table on Comparison by End-user
Exhibits 94: Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 102: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
Exhibits 104: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 105: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits 106: Market opportunity by End-user ($ million)
Exhibits 107: Data Table on Market opportunity by End-user ($ million)
Exhibits 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 109: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 110: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 111: Chart on Geographic comparison
Exhibits 112: Data Table on Geographic comparison
Exhibits 113: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on South Korea - Year-over-year growth 2024-2029 (%)

Executive Summary

The following companies are recognized as the key players in the global peripheral neuropathy treatment market: Apotex Inc., ASSERTIO HOLDINGS INC., AstraZeneca Plc, Cadila Pharmaceuticals Ltd., Cipla Inc., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Grunenthal GmbH, Hikma Pharmaceuticals Plc, Johnson and Johnson Services Inc., Lupin Ltd., Novartis AG, Pfizer Inc., SHIONOGI Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., UCB SA, and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong drug pipeline."

According to the report, one of the major drivers for this market is the increasing prevalence of peripheral neuropathy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Apotex Inc.
  • ASSERTIO HOLDINGS INC.
  • AstraZeneca Plc
  • Cadila Pharmaceuticals Ltd.
  • Cipla Inc.
  • Daiichi Sankyo Co. Ltd.
  • Dr Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Endo International Plc
  • Grunenthal GmbH
  • Hikma Pharmaceuticals Plc
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Novartis AG
  • Pfizer Inc.
  • SHIONOGI Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • UCB SA
  • Viatris Inc.

Related Topics

Related Reports

Chemotherapy Induced Peripheral Neuropathy Treatment Market by Treatment Type, Route of Administration, Patient Age Group, Therapy Duration, End-User - Global Forecast to 2030 - Product Image

Chemotherapy Induced Peripheral Neuropathy Treatment Market by Treatment Type, Route of Administration, Patient Age Group, Therapy Duration, End-User - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Diabetic Peripheral Neuropathy Market by Treatment Type, Route of Administration, Age Group, End-User - Global Forecast to 2030 - Product Image

Diabetic Peripheral Neuropathy Market by Treatment Type, Route of Administration, Age Group, End-User - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Peripheral Neuropathy Market Report 2025 - Product Image

Peripheral Neuropathy Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Diabetic Peripheral Neuropathy Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035 - Product Image

Diabetic Peripheral Neuropathy Market - A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Treatment Market Report 2025 - Product Image

Chemotherapy Induced Peripheral Neuropathy Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Neuropathy Drug Market

The Neuropathy Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases and disorders of the brain, spinal cord, and peripheral nervous system. Neuropathy drugs are used to treat a variety of conditions, including diabetic neuropathy, postherpetic neuralgia, and chemotherapy-induced peripheral neuropathy. These drugs are typically administered orally, intravenously, or topically, and may include anticonvulsants, antidepressants, and opioids. The Neuropathy Drug market is highly competitive, with a variety of companies offering products to treat a range of conditions. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Merck, and Johnson & Johnson. Other companies, such as Eli Lilly, Sanofi, and AstraZeneca, also offer products in this market. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.